New hope for rare blood disorder: drug cuts recurrence risk in japanese patients
NCT ID NCT04074187
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 23 times
Summary
This study tested a drug called caplacizumab in 21 Japanese adults with acquired thrombotic thrombocytopenic purpura (aTTP), a rare condition causing dangerous blood clots. The goal was to see if the drug could prevent the disease from coming back. Participants received caplacizumab alongside standard plasma exchange treatment. The study found that the drug helped reduce recurrence and improve platelet counts, but patients may still need ongoing management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOTIC THROMBOCYTOPENIC PURPURA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number 3920001
Kitakyushu-Shi, Japan
-
Investigational Site Number 3920002
Kumamoto, Japan
-
Investigational Site Number 3920003
Kurashiki-Shi, Japan
-
Investigational Site Number 3920005
Maebashi, Japan
-
Investigational Site Number 3920006
Sendai, Japan
-
Investigational Site Number 3920007
Kashihara-shi, Japan
-
Investigational Site Number 3920009
Iruma-Gun, Japan
-
Investigational Site Number 3920010
Kyoto, Japan
-
Investigational Site Number 3920011
Osaka, Japan
-
Investigational Site Number 3920013
Kawasaki-Shi, Japan
-
Investigational Site Number 3920014
Kanazawa, Japan
-
Investigational Site Number 3920015
Nagoya, Japan
Conditions
Explore the condition pages connected to this study.